Skip to content

Medical-device intelligence

Ever Fortune.Ai, Co., Ltd.: FDA clearances and recalls

Research Ever Fortune.Ai, Co., Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

16 clearance records and 0 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Sep 10, 2021 to Oct 30, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202610
February 202600
March 202600
April 202610
May 202600
June 202600
July 202600
August 202600
September 202600
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

16 matching records
Device / recordCompany in FDA recordSourceSource date
EFAI NEUROSUITE CTA LVO ASSESSMENT SYSTEM (LVO-CTA-100)K263109 · QASEver Fortune.Ai, Co., Ltd.510(k)Oct 30, 2026FDA decision date
EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)K253163 · QASEver Fortune.Ai, Co., Ltd.510(k)Apr 22, 2026FDA decision date
Seg Pro V3 (RT-300)K251306 · QKBEver Fortune.Ai, Co., Ltd.510(k)Jan 28, 2026FDA decision date
EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)K242821 · QASEver Fortune.Ai, Co., Ltd.510(k)Feb 20, 2025FDA decision date
EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)K241923 · QASEver Fortune.Ai, Co., Ltd.510(k)Dec 6, 2024FDA decision date
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)K234042 · QIHEver Fortune.Ai, Co., Ltd.510(k)Jun 7, 2024FDA decision date
EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEMK240291 · QASEver Fortune.Ai, Co., Ltd.510(k)Apr 8, 2024FDA decision date
EFAI NeuroSuite CT ICH Assessment SystemK231025 · QASEver Fortune.Ai, Co., Ltd.510(k)Oct 4, 2023FDA decision date
EFAI RTSUITE CT HCAP-Segmentation SystemK231928 · QKBEver Fortune.Ai, Co., Ltd.510(k)Sep 25, 2023FDA decision date
Efai Pacs Picture Archiving and Communication System ProK232100 · LLZEver Fortune.Ai, Co., Ltd.510(k)Aug 8, 2023FDA decision date
EFAI ChestSuite XR Pneumothorax Assessment SystemK221552 · QFMEver Fortune.Ai, Co., Ltd.510(k)Nov 8, 2022FDA decision date
EFAI ChestSuite XR Pleural Effusion Assessment SystemK222076 · QFMEver Fortune.Ai, Co., Ltd.510(k)Sep 8, 2022FDA decision date
EFAI CARDIOSUITE SPECT Myocardial Perfusion Agile WorkflowsK213731 · KPSEver Fortune.Ai, Co., Ltd.510(k)May 31, 2022FDA decision date
EFAI RTSuite CT HN-Segmentation SystemK220264 · QKBEver Fortune.Ai, Co., Ltd.510(k)Apr 28, 2022FDA decision date
EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment SystemK212624 · QIHEver Fortune.Ai, Co., Ltd.510(k)Apr 4, 2022FDA decision date
EFAI PACS Picture Archiving and Communication SystemK211257 · LLZEver Fortune.Ai, Co., Ltd.510(k)Sep 10, 2021FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗